Derek Mazur is an investment professional and the Director at Cedar Pine, where they focus on venture capital, growth equity, and buyout investments, leading opportunities in healthcare and AI/ML. Previously, Derek held the position of Director of Portfolio Management at Paragon Biosciences, launching a regenerative cell therapy company and overseeing the first FDA-approved AI diagnostic technology for breast cancer. Their earlier experience includes roles at Santé Ventures and SunTrust Robinson Humphrey, contributing to significant advancements in biotechnology and healthcare services. Derek holds a Master of Science in Biotechnology from Johns Hopkins University and a Bachelor of Business Administration in Finance from Emory University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices